Where Models Data and Teams Work as One
We developed ModelFlow, the digital backbone for pharma process development. Made for pharma, by pharma.
Created by scientists and engineers from:
Accelerate Drug Development
Streamlined Workflows
Collaboration
Faster results
Increased ROI
Optimize your pharma process in one place
Connecting data, models, and teams into a unified platform for faster, more reliable biopharma progress.
Transforming fragmented development steps into an integrated, optimized process.
Simplifying all therapeutic modalities
Our platform is designed to delivering all therapeutic modalities, with libraries of workflows structured to handle any of them effectively.
Small Molecule
Core treatments with precise targeting and established efficacy.
Oligonucleotides
Next-gen therapies using synthetic DNA or RNA fragments.
Biopharm & Sterile
Advanced biological therapies and sterile formulations for critical care.
Vaccines
Protective immunizations harnessing cutting-edge biotechnological advances.
Small Molecule
Core treatments with precise targeting and established efficacy.
Oligonucleotides
Next-gen therapies using synthetic DNA or RNA fragments.
Biopharm & Sterile
Advanced biological therapies and sterile formulations for critical care.
Vaccines
Protective immunizations harnessing cutting-edge biotechnological advances.
Achieve more and faster with ModelFlow
The right workflow for your pharmaceutical products, powered by the most advanced model and application library.
Get tailored model recommendations that support robust process and product development across the full lifecycle.
Case study
Connecting innovative teams and impactful products
Global Biopharmaceutical Leader
How Did ModelFlow’s End-to-End Digital Twin for Reactive Crystallization, Filtration, Washing, and Drying Accelerate the Development of a Second-Generation On-Market Blockbuster
80+
Lab experiments replaced through in-silico simulation
$200M
Informed a $200M facility investment decision
3+
Months saved via accelerated digital optimization
2L - 10,000L
Scale-up achieved digitally, eliminating 12 experiments at scale
Top 5 Global Healthcare Company
PolyModels Hub derives actionable insights from process, lab, and operations data to enhance yield and reduce suboptimal production.
50+
Suboptimal batches identified, representing ~10% of yearly production
$60M/year
Estimated annual value captured after implementing process changes
4+
Manufacturing sites achieving reproducible results through standardized models
150+
Process days recovered by avoiding rework of suboptimal batches
Leading European Pharmaceutical Company
How Does ModelFlow’s End-to-End Modeling Drive Results for a New Continuous Manufacturing Process of a Pipeline Blockbuster?
100+
Lab experiments reduced using in-silico runs
$3M
Development cost savings
3+
Months saved in development time
10+
Large-scale batch runs avoided
Top 5 Global Healthcare Company
How Did ModelFlow’s Digital Workflows Optimize Protein A Resin Usage and Accelerate Scale-Up for a Second-Generation Biologic?
4-Cycle
Optimized plan extending resin productivity while safeguarding resin life
$2M/year
Savings achieved through in-silico optimization of resin cycles
4
Large-scale campaign time saved via virtual DoE and risk analysis
2
Only two confirmatory experiments required for process validation
Accelerate pharma
process development.
Transform lives.
© Copyright 2025
Branded & Designed by HØLY™